Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

HRTSvsIXJETF Comparison

ETF 1
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
+1.34%
VS
ETF 2
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
+2.36%

Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belongs to the Tomorrow's Treatments segment. iShares Global Healthcare ETF (IXJ) is part of the Global Large Cap segment. Both ETFs have the same top 3 sector exposures: and Healthcare. HRTS is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.4% for IXJ. HRTS is up 4.32% year-to-date (YTD) with -$2M in YTD flows. IXJ performs better with 4.9% YTD performance, and -$530M in YTD flows. Run a side-by-side ETF comparison of HRTS and IXJ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HRTS vs IXJ performance and flow charts

Performance

-1.00.01.02.03.04.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

0 M50 M100 M150 M200 MJun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
HRTS
IXJ
+1.63%+2.87%
+9.49%+9.83%
+4.32%+4.90%
+31.36%+20.30%
n/a+23.01%
n/a+26.12%
Flows
HRTS
IXJ
-+$175M
-$70K+$199M
-$2M-$530M
-$6M-$281M
--$520M
-+$195M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HRTS
IXJ
+17.44%+17.32%
+16.04%+15.40%
n/a+13.91%
n/a+14.35%
Max drawdown
HRTS
IXJ
-4.69%-3.91%
-10.68%-10.83%
n/a-18.04%
n/a-18.04%
Max drawdown duration
HRTS
IXJ
23d22d
170d122d
n/a490d
n/a490d
Trading data

Create an account to view trading data

Join for free
HRTS
IXJ
Last sale
7/31/2026 at 1:30 PM
$36.43
$100.26
Previous close
07/30/2026
$36.90
$101.24
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HRTS
IXJ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
HRTS
IXJ
Last price
$36.43
$100.26
1D performance
-1.26%
-0.97%
AuM$54.92 M$4.13 B
E/R0.99%0.4%
Characteristics
HRTS
IXJ
Management strategyActivePassive
ProviderTemaiShares
Benchmark-S&P Global 1200 Health Care (Sector) Capped Index
N° of holdings43110
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 21, 2023November 13, 2001
ESGNoNo
Advertisement
Exposure

Countries

HRTS
USA
76.55%
Switzerland
7.26%
Other
16.19%
IXJ
USA
69.49%
Switzerland
10.37%
Other
20.14%

Sectors

HRTS
Healthcare
99.57%
Other
0.43%
IXJ
Healthcare
96.99%
Other
3.01%
Advertisement

Diversification

HRTS

Total weight of top 15 holdings out of 15

64.29%
IXJ

Total weight of top 15 holdings out of 15

57.47%

Top 15 holdings

Data as of June 30, 2026
HRTS
Eli Lilly & Co.
11.91%
UnitedHealth Group, Inc.
5.58%
Novo Nordisk A/S
5.25%
Merck & Co., Inc.
4.11%
Roche Holding AG
3.96%
Thermo Fisher Scientific, Inc.
3.91%
AstraZeneca PLC
3.85%
Johnson & Johnson
3.84%
Revolution Medicines, Inc.
3.64%
Cytokinetics, Inc.
3.40%
Novartis AG
3.30%
Gilead Sciences, Inc.
3.09%
Vertex Pharmaceuticals, Inc.
3.04%
Abbott Laboratories
2.71%
Danaher Corp.
2.70%
IXJ
Eli Lilly & Co.
10.92%
Johnson & Johnson
7.04%
AbbVie, Inc.
5.12%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.12%
AstraZeneca PLC
3.77%
Roche Holding AG
3.76%
Novartis AG
3.73%
Amgen, Inc.
2.54%
Thermo Fisher Scientific, Inc.
2.42%
Abbott Laboratories
2.05%
Gilead Sciences, Inc.
2.03%
Novo Nordisk A/S
1.99%
Intuitive Surgical, Inc.
1.83%
Pfizer Inc.
1.78%
Frequently asked questions about HRTS and IXJ

How have the HRTS and IXJ ETFs performed in 2026?

As of July 30, 2026, HRTS is up 4.32% year-to-date (YTD), while IXJ has returned 4.9%. That puts IXJ better performer ahead so far this year.

Which ETF is attracting more investor money: HRTS or IXJ?

Year-to-date, the HRTS ETF saw -$2M in flows, compared to -$530M for IXJ.

Which ETF is more volatile: HRTS or IXJ?

Over the past year, HRTS had a volatility of 16.04%, while IXJ experienced 15.4%.

Which ETF is bigger: HRTS or IXJ?

As of July 30, 2026, HRTS holds $54.92 M in assets under management (AUM), while IXJ manages $4.13 B.

What sectors do the HRTS and IXJ ETFs invest in?

HRTS leans toward sectors like Healthcare. Meanwhile, IXJ focuses on Healthcare.

What are the top holdings of the HRTS ETF and IXJ ETF?

HRTS top holdings include Eli Lilly & Co., UnitedHealth Group, Inc. and Novo Nordisk A/S. IXJ holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: HRTS or IXJ?

HRTS holds 43 securities with 64.29% of its assets in the top 15. IXJ has 111 securities and a top 15 weight of 57.47%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder